NMR vs. MS
NMR (Nomura Holdings, Inc.) and MS (Morgan Stanley) are both stocks. Both operate in the Capital Markets industry within the Financial Services sector. Over the past 10 years, NMR returned 11.05%/yr vs 28.45%/yr for MS. At a 0.33 correlation, their price movements are largely independent.
Performance
NMR vs. MS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NMR achieves a 5.05% return, which is significantly lower than MS's 28.71% return. Over the past 10 years, NMR has underperformed MS with an annualized return of 11.05%, while MS has yielded a comparatively higher 28.45% annualized return.
NMR
- 1D
- -4.11%
- 1M
- 6.54%
- YTD
- 5.05%
- 6M
- 5.17%
- 1Y
- 46.97%
- 3Y*
- 37.67%
- 5Y*
- 14.67%
- 10Y*
- 11.05%
MS
- 1D
- -0.47%
- 1M
- 12.44%
- YTD
- 28.71%
- 6M
- 27.30%
- 1Y
- 72.75%
- 3Y*
- 43.83%
- 5Y*
- 24.98%
- 10Y*
- 28.45%
NMR vs. MS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NMR Nomura Holdings, Inc. | 5.05% | 54.10% | 34.05% | 21.84% | -10.28% | -18.76% | 4.39% | 38.71% | -36.08% | 0.16% |
MS Morgan Stanley | 28.71% | 45.16% | 39.73% | 13.93% | -10.34% | 46.65% | 38.09% | 32.67% | -22.76% | 26.61% |
Correlation
The correlation between NMR and MS is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.42 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.45 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.44 |
Correlation (All Time) Calculated using the full available price history since May 16, 1995 | 0.33 |
The correlation between NMR and MS shifts across timeframes, from 0.33 (all time) to 0.51 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
NMR:
$26.29B
MS:
$360.07B
NMR:
¥118.76
MS:
$11.41
NMR:
11.76
MS:
19.80
NMR:
0.29
MS:
1.86
NMR:
0.89
MS:
3.00
NMR:
1.15
MS:
3.44
NMR:
¥4.76T
MS:
$120.22B
NMR:
¥2.17T
MS:
$69.72B
NMR:
¥608.09B
MS:
$27.21B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NMR vs. MS — Risk / Return Rank
NMR
MS
NMR vs. MS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nomura Holdings, Inc. (NMR) and Morgan Stanley (MS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NMR | MS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.27 | ||
| Sortino ratioReturn per unit of downside risk | -1.32 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.46 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | 2.10 | 3.88 | -1.78 |
| Martin ratioReturn relative to average drawdown | 5.65 | 12.81 | -7.16 |
Loading charts...
Drawdowns
NMR vs. MS - Drawdown Comparison
The maximum NMR drawdown since its inception was -89.27%, roughly equal to the maximum MS drawdown of -88.12%. Use the drawdown chart below to compare losses from any high point for NMR and MS.
Loading charts...
Drawdown Indicators
| NMR | MS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.27% | -88.12% | -1.15% |
Max Drawdown (1Y)Largest decline over 1 year | -22.43% | -18.83% | -3.60% |
Max Drawdown (3Y)Largest decline over 3 years | -26.34% | -29.24% | +2.90% |
Max Drawdown (5Y)Largest decline over 5 years | -40.69% | -32.38% | -8.31% |
Max Drawdown (10Y)Largest decline over 10 years | -55.34% | -51.33% | -4.01% |
Current DrawdownCurrent decline from peak | -56.70% | -0.47% | -56.23% |
Average DrawdownAverage peak-to-trough decline | -61.49% | -33.66% | -27.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.33% | 5.70% | +2.63% |
Volatility
NMR vs. MS - Volatility Comparison
Nomura Holdings, Inc. (NMR) has a higher volatility of 8.64% compared to Morgan Stanley (MS) at 7.76%. This indicates that NMR's price experiences larger fluctuations and is considered to be riskier than MS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NMR | MS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.64% | 7.76% | +0.88% |
Volatility (6M)Calculated over the trailing 6-month period | 23.02% | 21.58% | +1.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.16% | 25.85% | +4.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.82% | 28.67% | +1.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.60% | 31.34% | -0.74% |
Dividends
NMR vs. MS - Dividend Comparison
NMR's dividend yield for the trailing twelve months is around 3.75%, more than MS's 1.77% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MS Morgan Stanley | 1.77% | 2.17% | 2.82% | 3.49% | 3.47% | 2.14% | 2.04% | 2.54% | 2.77% | 1.72% | 1.66% | 1.73% |
NMR Nomura Holdings, Inc. | 3.75% | 4.91% | 4.29% | 1.20% | 3.86% | 0.00% | 0.86% | 0.00% | 0.00% | 1.70% | 1.79% | 3.34% |
Financials
NMR vs. MS - Financials Comparison
This section allows you to compare key financial metrics between Nomura Holdings, Inc. and Morgan Stanley. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NMR vs. MS - Profitability Comparison
NMR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nomura Holdings, Inc. reported a gross profit of 723.15B and revenue of 1.36T. Therefore, the gross margin over that period was 53.2%.
MS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Morgan Stanley reported a gross profit of 20.48B and revenue of 33.15B. Therefore, the gross margin over that period was 61.8%.
NMR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nomura Holdings, Inc. reported an operating income of 107.67B and revenue of 1.36T, resulting in an operating margin of 7.9%.
MS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Morgan Stanley reported an operating income of 7.01B and revenue of 33.15B, resulting in an operating margin of 21.2%.
NMR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nomura Holdings, Inc. reported a net income of 73.93B and revenue of 1.36T, resulting in a net margin of 5.4%.
MS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Morgan Stanley reported a net income of 5.64B and revenue of 33.15B, resulting in a net margin of 17.0%.
Frequently Asked Questions
NMR and MS have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NMR has higher volatility (8.64%) compared to MS (7.76%). In terms of maximum drawdown, NMR dropped -89.27% vs MS's -88.12%.
MS currently has the higher Sharpe Ratio (2.83 vs 1.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NMR and MS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer